Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma

NCT05738161 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped IMP security Issues reported by Sponsor

Conditions

Advanced Urothelial Carcinoma

Interventions

DRUG: Magrolimab
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]
[object Object]